Sema4D, also known as CD100, is a constitutively expressed immune semaphorin on T and NK cells. CD100 has important immune regulatory functions that improve antigenspecific priming by antigen-presenting cells and can also act as a co-stimulatory molecule on T cells. We investigated the consequence of HIV-1 infection on CD100 expression by T cells and whether CD100 expression signifies functionally competent effector cells.
Introduction
Semaphorins are a family of proteins that are traditionally associated with neuronal development and guidance. Immune semaphorins represent a small number of semaphorins expressed on immune cells. Sema4D, also called CD100, was the first immune semaphorin discovered and is abundantly expressed by resting T and NK cells 1 .
CD100 is a 150 kDa transmembrane glycoprotein that can be proteolytically cleaved into a soluble form 2 . CD100 utilizes a dual receptor system where it binds Plexin-B1 in nonlymphoid tissues 3 and CD72 in the immune system 4 . CD72 is present on the surface of most antigen-presenting cells (APCs) and B cells, and interaction with CD100 leads to dendritic cell maturation and cytokine production, and enhanced B cell activation 5, 6 .
Studies in CD100 -/-mice have demonstrated the importance of CD100 for both humoral and cellular immune responses. CD100 -/-mice have normal T and B cell numbers, but specific effector functions are impaired including T cell priming and B cell responsiveness 7 . Interestingly, T cells from CD100 -/-mice respond normally following mitogen or anti-CD3 antibody stimulation 7 suggesting the CD100-CD72 interaction is not essential for direct T cell receptor (TCR) stimulation, but is required for effective APC presentation of peptide to antigen-specific T cells. This is further supported by the physical interaction of CD100 and CD45 during T cell activation where CD100
potentially acts as a co-stimulatory molecule 8 . Additionally, CD100 appears to be important for differentiation into effector T cells 5, 8, 9 .
The importance of CD8 + T cell immunity during HIV-1 infection is well established. As HIV-1-specific CD8 + T cells emerge during acute infection, plasma viremia rapidly decreases [10] [11] [12] . Lymphocytes isolated from HIV-1-infected individuals with high viral loads have decreased effector functions (i.e. lack of detectable HIV-1-specific cytotoxicity, cytokine production and the ability to proliferate) [13] [14] [15] [16] . However, a rare subset of HIV-1-infected individuals, termed "elite" controllers, is capable of durably suppressing viremia below the level of detection without antiretroviral therapy 17 . The mechanisms behind non-progressive HIV-1 infection in "elite" controllers are still not clear, but appear to be genetically linked with an over-representation of HLA B57 and HLA B27 alleles [18] [19] [20] and more responsive CD8 + T cells [21] [22] [23] . These genetic and functional progression than viral load [24] [25] [26] [27] . However, these markers do not measure the functional capacity of CD8 + T cells. Instead, PD-1 and CD57 have been used to define terminally differentiated, exhausted, or dysfunctional T cells [28] [29] [30] [31] , although correlations between PD-1 and polyfunctionality of antigen-specific CD8 + T cells have not always been observed 31 . Therefore, additional markers capable of correlating with T cell function are urgently needed to monitor immune function, treatment responses, and T cell-mediated vaccines in HIV-1-infected persons (e.g. measles, mumps, rubella, varicella, and possibly in future, therapeutic HIV-1 vaccines).
There are undoubtedly several factors involved in HIV-1-related immune dysfunction, but accumulating evidence indicates that CD100 plays a relevant role in immune regulation and enhancement of effector functions 5, 8, 9, 32, 33 . We hypothesized that lower levels of CD100 reduce effector functions that render T cells incapable of optimally responding to pathogens. We utilized subjects at different stages of HIV-1 infection to determine the effect of infection on CD100 expression and to assess the potential role of CD100 for CD8 + T cell responses.
Materials and Methods

Study subjects
Cryopreserved peripheral blood mononuclear cells (PBMC) from 138 HIV-1-infected subjects from three different cohorts (University of California San Francisco (UCSF)
Options cohort, UCSF SCOPE cohort, and the pediatric HIV-1 clinic at Jacobi Medical Center, Bronx, NY) were used in this study. PBMC from 30 healthy blood donors from the Stanford Blood Center, Palo Alto, CA and 10 from San Francisco, CA were included 
IFN-γ ELISPOT assay
T cell responses were assessed by IFN-γ ELISPOT as previously described 35 . The HIV-1
Gag p24 15-mer peptide pool (2 μg/ml) (NIH AIDS Research and Reference Reagents
Program, Bethesda, MD) or phytohaemagglutinin (PHA) (1 μg/ml, Sigma, St Louis, MO)
were used for stimulation. FACS sorted cells were stimulated with phorbol myristate acetate (PMA) (50 ng/ml, Sigma) and ionomycin (1 μg/ml, Sigma). Average spot counts for duplicate wells were calculated and background from wells with cells in media only was subtracted. Wells containing more than 50 spot-forming units following subtraction of two times background were considered a positive response.
Cell sorting
PBMC from healthy individuals were sort-purified based on CD100 staining on CD8 + T cells using a BD FACS Aria (BD Biosciences). Purity of sorted cells was consistently >
97%.
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Pentamer staining
Antigen-specific CD8 + T cells were assessed for CD100 expression using biotinylated MHC class I pentamers (ProImmune, Oxford, UK) per manufacturer's instructions.
Multiplex cytokine array
CD100
+ or CD100 neg CD8 + T cells were co-cultured with autologous peptide-pulsed PBMC. Peptide-pulsing was performed with peptides from CMV [NLVPMVATV (HLA A2-restricted), QIKVRVDMV (HLA B8-restricted) or TPRVTGGGAM (HLA B7-restricted)] at 10 μg/ml at 37°C for 1 hour followed by irradiation (Gammacell 3000, MDS Nordion, Ontario, Canada) at 5000 rads. PBMC were washed extensively with complete culture medium. Supernatants were collected after 24 hours of co-culture. 
In vitro HIV-1 infection of PBMC
PBMC from HIV-1-negative donors were stimulated with 2 μg/ml PHA and infected on day three with NL4-3 by spinoculation (1200 x g for 2 hours) at a multiplicity of infection of 0.05 per 5x10 5 cells. PBMC were maintained in culture in the presence of 50 IU/ml IL-2 and were assessed for changes in CD100 expression on day 7 post-infection.
Intracellular cytokine staining
5 x 10 5 PBMC were stimulated with PHA (1 μg/ml), CEF (5 μg/ml), p24 peptide pools (5 μg/ml), 9-mer HIV or 9-mer CMV peptides (5 μg/ml) in the presence of anti-CD49d and
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From anti-CD28 (clone 9F10 and L293 respectively, 1 μg/ml each; BD Biosciences). After one hour brefeldin A was added (10 μg/ml) and the cells incubated for an additional five hours. T cell expression of IFNγ (clone B27, BD Biosciences) was performed by intracellular cytokine staining.
Cytokine stimulation
Fresh PBMC (5x10 5 cells) were stimulated in a 96 well round-bottom plate with the following conditions: IL-6 (10 ng/ml), IFNγ (50 ng/ml), TNFα (10 ng/ml), IL-12/IL-18 (50 ng/ml each), IL-15 (25 ng/ml), IL-7 (25 ng/ml), IL-1β (50 pg/ml), anti-CD3/anti-CD28 (clone Hit3α and L293 respectively -1 μg/ml of each). After 24 hours of incubation, cells were assessed for the frequency and gMFI of CD100 expression by flow cytometry.
Statistical analysis
All statistical analyses were performed using Prism 4.0 (GraphPad software). Flow cytometry data was analyzed using student's T-test or Kruskal-Wallis test followed by the Dunn post-test as indicated. Correlation coefficients were determined by Spearman rank correlation. Area under the curve (AUC) analysis was calculated by the trapezoidal method. P values based on two-tailed tests were considered statistically significant when p < 0.05.
Results
CD100 frequency and fluorescence intensity is decreased on CD8 + and CD4 + T cells during HIV-1 infection
CD100 is highly expressed on resting T cells in healthy individuals, however the effect of HIV-1 infection on CD100 expression has never been studied. A cross-sectional analysis of PBMC from individuals with early HIV-1 infection (within first year of infection), elite controllers (EC), and non-controllers (NC; Supplemental significantly lower in all HIV-1-infected groups compared to healthy controls ( Fig 1C) .
Furthermore, the geometric mean fluorescence intensity (gMFI) of CD100 on CD8 + T cells was significantly decreased in both the EC (mean gMFI = 746.5) and NC (mean gMFI = 751) compared to healthy controls (mean gMFI = 910.1; Fig 1D) . The mean CD100 gMFI on CD4 + T cells was significantly decreased only in early HIV-1-infected subjects ( Fig 1D) . Taken together, CD100 expression on CD4 + and CD8 + T cells and the percentage of CD100 + T cells decline during HIV-1 infection.
CD100 expression on total CD8 + T cells is disrupted during early HIV-1 infection, persists through chronic infection and is not restored upon ART initiation
To determine whether CD100 expression changed over the course of infection, we Importantly, initiation of ART did not appear to have a significant effect on the frequency or gMFI of CD100 expression. These data suggest CD100 expression is altered during acute infection and persists through chronic infection despite effective ART viral suppression. skews the ratio of naïve and memory T cell populations in the periphery towards greater frequencies of the latter subsets 36, 37 . Therefore, we hypothesized that sustained ART for greater than one year would significantly shift the proportion of naïve and memory T cells and restore the frequency of CD100 expression. We analyzed CD100 expression on naïve, central memory (TCM), effector memory (TEM) and terminally differentiated effector memory (TEMRA) CD8 + T cells using CCR7 and CD45RA ( groups although most subjects receiving ART had undetectable HIV-1 RNA plasma viral loads. The number of naïve T cells expressing CD100 significantly decreased in untreated patients compared to healthy controls ( Fig 2B) . ART significantly increased the number of CD100 + naïve T cells, although this was nearly two-fold less than healthy controls. Treatment had a small, but significant, effect on the number of CD100 + TCM compared to untreated subjects (42 vs 17 cells/mm 3 ). In contrast, the absolute numbers of CD100-expressing TEM and TEMRAs increased 3.6 and 4.6-fold respectively in untreated subjects and 3.5 and 4-fold in the ART group compared to healthy controls. To account for the typical expansions in total CD8 + T cell counts that occur during HIV-1 infection and ART, we assessed the percentage of each CD8 + T cell subset expressing CD100. Despite a significant increase in the absolute number of CD100-expressing TEM and TEMRA in untreated and ART subjects, the mean CD100 frequency was significantly decreased within all CD8 + T cell subsets in both untreated and ART individuals compared to healthy individuals (Fig 2C) . Similarly, the mean gMFI was also reduced in all CD8 + T cell subsets for both patient groups compared to healthy controls ( Fig 2D) . These data indicate that loss of CD100 expression on CD8 + T cells during HIV-and the frequency of CD100 expression are decreased on all CD8 + T cell subsets.
Furthermore, the expansion of the absolute number of CD100-expressing CD8 + T cells observed during chronic infection (Fig 1A) results from the expanded CD100-expressing TEM and TEMRA subsets. Despite ART-induced viral control, ART has minimal impact on improving CD100-expressing CD8 + T cells.
The magnitude of the HIV-1-specific T cell response is related to CD100 expression
CD100 is important for T cell co-stimulation and differentiation into effector cells 5, 8, 9, 32 .
Therefore we hypothesized that the number of CD100 + CD8 + T cells would directly relate to the magnitude of the antigen-specific T cell responses. To elucidate whether antigenspecific CD8 + T cells in general, or if HIV-1-specific CD8 + T cells in particular, had decreased CD100 expression in HIV-1-infected patients, pentamer staining was performed on PBMCs from seronegative and chronically HIV-1-infected individuals ( Fig   3A and B) . CMV or HIV-1 pentamer positive cells were then assessed for CD100 expression ( Fig 3C) . Overall, the frequency of CMV-and HIV-1-specific CD8 + T cells expressing CD100 was significantly lower in HIV-1-infected subjects compared to healthy individuals (Fig 3D) . In a subset of HIV-1-infected individuals (n = 9) we measured the frequency of both HIV-1-and CMV-specific CD100-expressing T cells by pentamer staining within the same individual. We observed a trend towards a lower frequency and gMFI of CD100 expression on HIV-1-specific, compared to CMVspecific, T cells within the same individual (Fig 3E and F) . This suggests that although the frequency and gMFI of CD100-expressing T cells generally appears to be lower in HIV-1-infected patients, CD100 expression on different antigen-specific T cells within the same HIV-1-infected individual may be different.
Additionally, we assessed the role of CD100 in the generation of total CD4 + and CD8 + T cell responses upon re-stimulation with HIV-1 antigens in untreated chronically infected subjects by IFN-γ ELISPOT following Gag p24 peptide pool stimulation. In patients with detectable viremia (n = 53), we observed a positive correlation between the number of CD100-expressing CD8 + T cells and spot-forming units (Fig 3G) . This association was predominantly attributed to the presence of CD8 + CD100 + naïve and TEMRA T cells ( Fig 3H and I) . Additionally, in untreated HIV-1-infected patients, including early, EC and NC individuals, a modest, but significant correlation between CD4 + T cell counts and the number of CD100 + CD8 + T cells was observed (Fig 3J) .
Loss of CD100 is related to immune activation status and viral loads CD100 + T cell frequencies are significantly decreased in all HIV-1-infected groups, however the absolute number of CD100-expressing cells in the total CD8 + T cell population is significantly increased in non-controllers (Fig 1A and C) . Therefore, an increased population of CD100 neg CD8 + T cells should be present in the periphery. Indeed, the mean frequency (data not shown) and absolute number (Suppl . Fig 1) (Fig 4B black line) . The correlation with viral load remained statistically significant after exclusion of the EC group (Fig 4B grey line) . Interestingly, calculation of the area under the curve for viral load prior to ART in the 12 early HIV-1-infected subjects showed that the number of CD100 neg CD8 + T cells present during the first year of infection was associated with viral control in the early stages of infection (Fig 4C) .
Decreased CD100 expression is associated with CD8 + T cell immunosenescence and exhaustion
Based on our observation that expansion of CD100 neg CD8 + T cells is associated with higher levels of immune activation and higher viral loads, we investigated co-expression of CD100 with the immunosenescence marker CD57 and the T cell regulatory marker PD-1. CD57 and PD-1 increase during HIV-1 infection and are associated with immune dysfunction 28, 29, 38, 39 . We hypothesized that increased frequencies of CD100 neg CD8 (Fig 4D) . In healthy donors, CD8 + T cells were predominantly CD100 + CD57 neg PD-1 neg (Fig 4D) . A positive correlation between the absolute numbers of CD100 neg CD8 + T cells and CD57 + or PD-1 + CD8 + T cells was also observed (Suppl .   Fig 2A and B) . Using HIV-and CMV-specific pentamers, we assessed co-expression of CD100, CD57, and PD-1 on antigen-specific CD8 + T cells. In HIV-1-infected subjects we observed ~20% of the HIV-specific CD8 + T cells were CD100 neg CD57 + PD-1 + compared to ~10% of CMV-specific CD8 + T cells, although this difference did not reach statistical significance (Fig 4E) . Interestingly, CD57 expression was observed on a significantly higher proportion of CMV-specific CD8 + T cells in the presence or absence of CD100 compared to HIV-1-specific CD8 + T cells. In contrast, ~20% of the HIV-1-specific CD8+ T cells were CD100 neg CD57 neg PD-1 + in comparison to only ~5% of CMVspecific CD8 + T cells and less than 5% of CMV-specific CD8 + T cells in uninfected controls. Taken together, these data indicate an emergence of a highly dysfunctional CD8 + T cell subset characterized by mainly PD-1 and to lesser extent CD57 coexpression in the absence of CD100 that appears to be particularly elevated on HIV-1-specific CD8 + T cells.
CD100 neg CD8 + T cells are functionally different in response to stimulation
To address the functional implications of altered CD100 expression on T cells, PBMCs from healthy individuals were FACS sorted into CD100 + or CD100 neg CD8 + T cell populations and assessed by ELISPOT assay. Compared to CD100 + T cells, the number of CD100 neg cells that produced IFN-γ following PMA/ionomycin stimulation was significantly lower (Fig 5A and B) . Additionally, Luminex analysis of PMA/ionomycin stimulated CD100 + and CD100 neg cell supernatants indicated a significant difference in the levels of IFN-γ, MIP-1β, TNF-α and perforin production between CD100 + CD8 + and CD100 neg CD8 + T cells (Fig 5C) . A trend toward greater IL-2 production from CD100 
Viral replication and pro-inflammatory cytokines do not induce the loss of CD100 expression on CD8 + T cells
To assess the potential mechanism(s) resulting in diminished CD100 expression on T cells, we assessed the influence of in vitro HIV-1 infection, cytokine administration, and antigen-specific stimulation on CD100 expression using both HIV-1-infected and uninfected donors. PBMC infected with NL4-3 for seven days did not exhibit a significant change in the frequency of CD100 + CD8 + T cells (data not shown) or the gMFI of CD100 expression (Fig 6A) . Similarly, culturing PBMC with pro-inflammatory (IL-1β, IL-6, IL-12 and IL-18, IFNγ, TNFα) and homeostatic cytokines (IL-7, IL-15) did not statistically change the frequency (data not shown) or gMFI of CD100 expression ( Fig   6B) . Direct TCR stimulation using anti-CD3 and anti-CD28 antibodies also did not significantly change the frequency (data not shown) or gMFI of CD100 expression ( Fig   6B) . To determine whether antigen-specific stimulation affected CD100 expression, PBMC from healthy controls or HIV-1-infected subjects were stimulated with CEF (healthy and HIV-1-infected subjects) or p24 (HIV-1-infected only) peptides in an intracellular cytokine-staining assay. Peptide stimulation induced IFNγ expression from CD100 neg CD8 + T cells (Fig 6C and D) . This result is in direct contrast to our findings that CD100 + CD8 + T cells respond with greater production of cytokines following PMA/ionomycin or peptides (Fig 5) , and suggests peptide stimulation induces a rapid loss of CD100 expression on responding T cells. To address this further, we measured CD100 expression on epitope-specific CD8 + T cell populations using MHC Class I (Fig 6E) .
Discussion
We observed a significant reduction in the frequency and gMFI of CD100 on both CD4 In HIV-1-negative individuals CD100 is highly expressed on resting T cells. A previous study indicated that CD100 expression can be differentially modulated by various stimuli; anti-CD3 antibody or PHA result in rapid up-regulation of CD100 whereas PMA decreased CD100 expression 32 . We observed that HIV-1 infection significantly decreased the frequency and fluorescence intensity of CD100 on both CD8 + and CD4 + T cells.
Interestingly, our data indicate there was either no re-expression or the rate of re- . CD57 and PD-1 expression on HIV-1-specific T cells are reported to be associated with HIV-1-related immune dysfunction and thus are proposed to contribute to lack of viral control 29, 30 . These data would therefore suggest that monitoring the coexpression of CD100, CD57, and PD-1 on HIV-1-specific T cells may be a better measure of the functionality of these cells than using any of these markers alone.
CD100 expression is regulated, at least partially, by proteolytic cleavage and activated T cells have been reported to be one source of soluble CD100 2, 42 . Although soluble CD100
was not measured in the sera of these cohorts, the rapid loss of CD100 following peptide stimulation suggests that CD100 is likely cleaved from the surface of activated T cells.
Interestingly, in vitro anti-CD3/anti-CD28 stimulation did not significantly change CD100 expression, however stimulation with peptides resulted in significant CD100 loss.
This suggests that cell-cell contact, which occurs during peptide presentation, is required for loss of CD100 surface expression. This is further supported by the observation that individual cytokines did not significantly change CD100 expression, although it is possible that the complex cytokine milieu in addition to chronic HIV-1 antigenemia in vivo enhances cleavage of CD100 or inhibits the re-expression of CD100 on antigenstimulated cells. Subjects assessed within three months of initiating ART, which decreases immune activation and plasma viral load, did not exhibit changes in the frequency or fluorescence intensity of CD100 expression. This is likely because even in the presence of ART, antigens are still present at significant levels either due to trapped virions in secondary lymphoid tissues or low-level viral replication in tissue sanctuaries.
However, sustained ART for greater than one year did partially restore the number of CD100-expressing naïve CD8 + T cells, although not to the levels observed in healthy individuals. These data illustrate the long-term damage induced by HIV-1 infection on T cell phenotype and function and suggest that complete reconstitution of immune cell function requires more than viral suppression alone.
CD100-CD72 signaling has been primarily focused on the CD72-induced signals following engagement with CD100. The functional significance of CD100 as a receptor on T cells is relatively limited. Studies found that membrane-bound CD100 is associated with serine kinase activity following antibody cross-linking 43 , that augments proliferation in the presence of sub-mitogenic levels of anti-CD3 and anti-CD2 32 . Additionally, CD100
was discovered to associate with CD45, an essential component for T cell activation via the TCR 44 . Collectively, these studies suggest that CD100 acts as a co-stimulatory molecule to enhance T cell responses. In agreement with these studies, we observed that HIV-1-specific IFN-γ production was associated with the absolute number of Conversely, T cells from CD100 -/-mice have been described to respond normally to PHA and anti-CD3 stimulation and were concluded to have no intrinsic deficiency 7 . However, differences in PHA and PMA signaling pathways have been described 45 , which could potentially account for the divergent results. Our studies of antigen-specific responses also showed very low levels of cytokine production in the sort-purified CD100 neg CD8 + T cell population, which suggests a potentially intrinsic deficiency in these cells.
Alternatively, it is possible that part of the decreased cytokine levels in the cells lacking CD100 may be due to antigen-induced apoptosis since CD100 has been implicated in leukemic pro-survival properties 46, 47 In conclusion, we observed that the CD8 + T cell population in HIV-1-infected subjects is altered from a highly CD100-expressing cell population to a population with increased 
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